Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Amphion lifted by promissory note conversion at assumed 8p per share

The company issued 1.66mln shares to the loan note holder
Pound notes
Amphion's coffers were swollen by £133,173

Amphion Innovations Plc (LON:AMP), the developer of medical, life science, and technology businesses, has received £133,173 through the conversion of promissory notes.

The company issued 1.66mln shares, representing 0.8% of the enlarged share capital, to the loan note holder.

The notes were converted at a price of 8p per share, prompting market makers to bump up the Amphion share price from 1.37p overnight to 1.85p.

View full AMP profile View Profile

Amphion Innovations Plc Timeline

RNS
January 10 2018
RNS
December 22 2017
RNS
December 05 2017
RNS
November 10 2017
RNS
November 02 2017
RNS
October 11 2017
RNS
September 29 2017

Related Articles

esports arena
December 08 2017
The AIM-listed group is well-placed to take advantage of the impending boom in the popularity of esports
Arnie, the Terminator
October 14 2017
The march of the machines ... Telit has placed itself firmly at the forefront of the next digital revolution - the Internet of Things (IoT).
Buying online
November 14 2017
The company toned down full-year revenue guidance after a review of procedures but is still growing like topsy

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use